amitriptyline has been researched along with Pulmonary Eosinophilia in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noh, H | 1 |
| Lee, YK | 1 |
| Kan, SW | 1 |
| Choi, KH | 1 |
| Ha, DS | 1 |
| Lee, HY | 1 |
1 other study available for amitriptyline and Pulmonary Eosinophilia
| Article | Year |
|---|---|
Acute eosinophilic pneumonia associated with amitriptyline in a hemodialysis patient.
Topics: Acute Disease; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Female; Humans; Pulmonary Eos | 2001 |